Cargando…
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates
Despite the success of currently authorized vaccines for the reduction of severe COVID-19 disease risk, rapidly emerging viral variants continue to drive pandemic waves of infection, resulting in numerous global public health challenges. Progress will depend on future advances in prophylactic vaccin...
Autores principales: | Seenappa, Lochana M., Jakubowski, Aniela, Steinbuck, Martin P., Palmer, Erica, Haqq, Christopher M., Carter, Crystal, Fontenot, Jane, Villinger, Francois, McNeil, Lisa K., DeMuth, Peter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616425/ https://www.ncbi.nlm.nih.gov/pubmed/36307453 http://dx.doi.org/10.1038/s41541-022-00560-3 |
Ejemplares similares
-
A lymph node–targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2
por: Steinbuck, Martin P., et al.
Publicado: (2021) -
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice
por: Dasari, Vijayendra, et al.
Publicado: (2023) -
The evolution of CpG density and lifespan in conserved primate and mammalian promoters
por: McLain, Adam T., et al.
Publicado: (2018) -
S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes
por: Nakagawa, Takayuki, et al.
Publicado: (2021) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016)